✨ Medicines Distribution Consent




4 SEPTEMBER 2008 NEW ZEALAND GAZETTE, No. 136 3623

Dated this 28th day of August 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6450

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Doxine

Active Ingredient: Doxycycline hyclate 115mg equivalent to doxycycline 100mg

Dosage Form: Tablet

New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)

Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India

Dated this 28th day of August 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6447

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Cubicin

Active Ingredient: Daptomycin 350mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Novartis New Zealand Limited

Manufacturer: Catalent Pharma Solutions LLC, Albuquerque, New Mexico, United States of America

Product: Cubicin

Active Ingredient: Daptomycin 500mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Novartis New Zealand Limited

Manufacturers: Catalent Pharma Solutions LLC, Albuquerque, New Mexico, United States of America
Hospira, Inc., McPherson, Kansas, United States of America

Product: Norprolac

Active Ingredients: Quinagolide hydrochloride 0.0273mg equivalent to 0.025mg quinagolide
Quinagolide hydrochloride 0.0546mg equivalent to 0.05mg quinagolide

Dosage Form: Tablet

New Zealand Sponsor: Pharmaco (NZ) Limited

Manufacturer: Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Product: Norprolac

Active Ingredient: Quinagolide hydrochloride 0.1638mg equivalent to quinagolide 0.15mg

Dosage Form: Tablet

New Zealand Sponsor: Pharmaco (NZ) Limited

Manufacturer: Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Product: Norprolac

Active Ingredient: Quinagolide hydrochloride 0.0819mg equivalent to quinagolide 0.075mg

Dosage Form: Tablet

New Zealand Sponsor: Pharmaco (NZ) Limited

Manufacturer: Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Dated this 28th day of August 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6446

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2008, No 136





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
28 August 2008
Medicines, Distribution, Doxine, Doxycycline, Pacific Pharmaceuticals, Intas Pharmaceuticals
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
28 August 2008
Medicines, Distribution, Cubicin, Daptomycin, Norprolac, Quinagolide, Novartis, Pharmaco
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to the Distribution of a New Related Product

πŸ₯ Health & Social Welfare
28 August 2008
Medicines, Distribution, New Related Product
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate